We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Position paper on laboratory testing for patients taking new oral anticoagulants. Consensus document of FCSA, SIMeL, SIBioC and CISMEL.
- Authors
Tripodi, Armando; Di Iorio, Giancarlo; Lippi, Giuseppe; Testa, Sophie; Manotti, Cesare
- Abstract
At variance with vitamin K antagonists, the new oral anticoagulants (NOAs) can be prescribed at fixed dosage without adjustment by laboratory testing. However, this does not necessarily mean that the laboratory does not play a role for their management. This position paper represents the consensus document of three Italian scientific societies dealing with laboratory issues in thrombosis and hemostasis. It is aimed at reviewing: 1) which test(s) should be used to evaluate the anticoagulant effect of each of the NOAs presently available (i.e., dabigatran, rivaroxaban and apixaban); 2) the patients to be investigated; and 3) the timing of investigation.
- Subjects
LABORATORIES; ANTICOAGULANTS; HEMATOLOGIC agents; VITAMIN K; FAT-soluble vitamins
- Publication
Clinical Chemistry & Laboratory Medicine, 2012, Vol 50, Issue 12, p2137
- ISSN
1434-6621
- Publication type
Article
- DOI
10.1515/cclm-2012-0327